The Biological Role of Cervical Cancer Suppressor 3 (CCS-3): Literature Review
- Authors
-
-
Luigi Cristiano
R&D Division, Prestige, Loro Ciuffenna (AR), Italy
-
- Keywords:
- Cancer, EEFs, Cervical cancer suppressor 3 (CCS-3), EEF1A, Apoptosis.
- Abstract
-
CCS-3 is one of the isoforms of eEF1A1, the key protein of the translation elongation step. Discovered in 2006, it has been the subject of some studies on human cervical cancer cell lines and cervical cancer samples. These studies brought to identify its probable role as a transcriptional co-repressor but other functions are currently unknown. It has also been shown that it is able to inhibit cell growth and induce apoptosis in the tumor cells that downregulate it. Further studies could highlight its functions and its possible usefulness as a tumor marker. This review aims to brief the research about CCS-3 that has been carried out so far.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Najia Mansoor, Rafeeq Alam Khan, Johannes Schueller, Dagmar Ettlinge, Philipp Buchner, Martin Czejka, Tasneem Ahmad, Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Lingling Liu, Taosheng Chen, PAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in Alveolar Rhabdomyosarcoma Cells , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Chiaki Tokoro, Atsushi Tashiro, Kenji Ina, Yoshiteru Tanaka, Hiroyuki Kobayakawa, Takashi Yoshida, Satoshi Kayukawa, Successful Treatment, with Chemotherapy and Intravenous Administration of Ascorbic Acid, of a Patient with Peripheral T-Cell Lymphoma, Not Otherwise Specified , Journal of Cancer Research Updates: Vol. 13 (2024)
- Nada A. Al-Hasawi, Ladislav Novotny, Quercetin and Mercury In Vitro Anti-Proliferative Effect in Human Astrocytoma Cells , Journal of Cancer Research Updates: Vol. 12 (2023)
- K. Pawinska-Wasikowska, T. Ksiazek, A. Wieczorek, M. Matysiak, B. Fic-Sikorska, E. Adamkiewicz-Drozynska, L. Maciejka-Kapuscinska, A. Chybicka, K. Potocka, J. Wachowiak, J. Skalska-Sadowska, J. Kowalczyk, B. Wojcik, M. Wysocki, S. Koltan, M. Krawczuk-Rybak, K. Muszynska-Roslan, W. Mlynarski, M. Stolarska, T. Urasinski, E. Kamienska, T. Szczepanski, R. Tomaszewska, G. Sobol-Milejska, A. Mizia-Malarz, G. Karolczyk, J. Pohorecka, M. Wieczorek, I. Karpinska-Derda, W. Balwierz, Is FLT3 Internal Tandem Duplication an Unfavorable Risk Factor for High Risk Children with Acute Myeloid Leukemia? - Polish Experience , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Ali El-Shekeil, Abeer Omer, Sama Al-Aghbari, Omar Al-Shuja'a, Anti-Cancer and Anti-Microbial Activity Studies of Some Complexes of Trimethoprim , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- Giovanni Luigi Capella, Clinicopathologic Dissociation in Dermat[onc]ology – and Beyond , Journal of Cancer Research Updates: Vol. 11 (2022)
- Tatiana I. Bulycheva, Svetlana A. Mayakova, Simon V. Skurkovich , Disease-Free Remission Exceeding 37 Years in Patients Treated as Children for Acute Leukemia (AL) with Immunotherapy Using Viable (Cryopreserved) Allogeneic Leukemic Cells Pages 254-26 , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr, Zhe-Sheng Chen, Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Riya Jacob, J. Jenkin Winston, Brain Tumor Segmentation using Osprey Optimization Assisted DeepLabV3+ Model , Journal of Cancer Research Updates: Vol. 14 (2025)
You may also start an advanced similarity search for this article.